Curcumin promotes differentiation of glioma‐initiating ...
Dr. Peter Sordillo is a member of the Scientific Advisory Board of SignPath Pharma, a developmental stage biotechnology company that is studying liposomal curcumin, liposomes and other agents. Dr. Helson is CEO of SignPath Pharma. Laura Sordillo reports no conflicts. 4. Abstract Title: Paraptosis in human glioblastoma … ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.